These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 42940)

  • 1. The regulation of insulin-induced and sleep-related human growth hormone secretion: a review.
    Mendelson WB; Jacobs LS; Gillin JC; Wyatt RJ
    Psychoneuroendocrinology; 1979 Oct; 4(4):341-9. PubMed ID: 42940
    [No Abstract]   [Full Text] [Related]  

  • 2. Methoscopolamine inhibition of sleep-related growth hormone secretion. Evidence for a cholinergic secretory mechanism.
    Mendelson WB; Sitaram N; Wyatt RJ; Gillin JC; Jacobs LS
    J Clin Invest; 1978 Jun; 61(6):1683-90. PubMed ID: 659621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of sleep-induced growth hormone secretion: no effect on diabetic control.
    Davidson MB; Peters AL
    Diabetes Care; 1990 Jul; 13(7):813-4. PubMed ID: 2257001
    [No Abstract]   [Full Text] [Related]  

  • 4. Scopolamine-induced muscarinic supersensitivity in normal man: changes in sleep.
    Sitaram N; Moore AM; Gillin JC
    Psychiatry Res; 1979 Jul; 1(1):9-16. PubMed ID: 233155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Growth hormone concentration following various factors stimulating its release].
    Nizankowska-Baz T; Korczowski R; Abramowicz T; Dudek A
    Pol Tyg Lek; 1992 Nov 2-9; 47(44-45):994-5. PubMed ID: 1305718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choline inhibits acetylcholine release via presynaptic muscarine receptors.
    Kilbinger H; Kruel R
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Apr; 316(2):131-4. PubMed ID: 7242699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piperidine enhances sleep-related and insulin-induced growth hormone secretion: further evidence for a cholinergic secretory mechanism.
    Mendelson WB; Lantigua RA; Wyatt RJ; Gillin JC; Jacobs LS
    J Clin Endocrinol Metab; 1981 Mar; 52(3):409-15. PubMed ID: 7007406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscarinic supersensitivity: a possible model for the sleep disturbance of primary depression?
    Gillin JC; Sitaram N; Duncan WC
    Psychiatry Res; 1979 Jul; 1(1):17-22. PubMed ID: 233154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine and amine studies in affective illness.
    Casper RC; Davis JM; Pandey GN; Garver DL; Dekirmenjian H
    Psychoneuroendocrinology; 1977; 2(2):105-13. PubMed ID: 23559
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta-adrenergic modulation of growth hormone (GH) autofeedback on sleep-associated and pharmacologically induced GH secretion.
    Kelijman M; Frohman LA
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1187-94. PubMed ID: 2573614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone responses to sleep, insulin hypoglycaemia and arginine infusion.
    Ward PS; Savage DC
    Horm Res; 1985; 22(1-2):7-11. PubMed ID: 3897015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological regulation of the human growth hormone (GH)-insulin-like growth factor type I (IGF-I) axis: predominant impact of age, obesity, gonadal function, and sleep.
    Veldhuis JD; Iranmanesh A
    Sleep; 1996 Dec; 19(10 Suppl):S221-4. PubMed ID: 9085516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral administration of CDP-choline and its cholinergic metabolites increases serum insulin: muscarinic and nicotinic acetylcholine receptors are both involved in their actions.
    Ilcol YO; Cansev M; Yilmaz MS; Hamurtekin E; Ulus IH
    Neurosci Lett; 2008 Jan; 431(1):71-6. PubMed ID: 18162319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. -Aminobutyrylcholine: actions on GABA and acetylcholine receptors.
    Bowery NG; Brown DA
    J Pharm Pharmacol; 1972 Aug; 24(8):663-6. PubMed ID: 4403753
    [No Abstract]   [Full Text] [Related]  

  • 15. Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep.
    Van Cauter E; Blackman JD; Roland D; Spire JP; Refetoff S; Polonsky KS
    J Clin Invest; 1991 Sep; 88(3):934-42. PubMed ID: 1885778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human serial learning: enhancement with arecholine and choline impairment with scopolamine.
    Sitaram N; Weingartner H; Gillin JC
    Science; 1978 Jul; 201(4352):274-6. PubMed ID: 351808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone secretion during sleep.
    Takahashi Y; Kipnis DM; Daughaday WH
    J Clin Invest; 1968 Sep; 47(9):2079-90. PubMed ID: 5675428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cholinergic muscarinic receptor blockade on human growth hormone (GH)-releasing hormone-(1-44)-induced GH secretion in anorexia nervosa.
    Tamai H; Komaki G; Matsubayashi S; Kobayashi N; Mori K; Nakagawa T; Truong MP; Walter RM; Kumagai LF
    J Clin Endocrinol Metab; 1990 Mar; 70(3):738-41. PubMed ID: 2106528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of human growth hormone secretion in sleep and waking.
    Mendelson WB
    Int Rev Neurobiol; 1982; 23():367-89. PubMed ID: 6126463
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of growth hormone sleep release and responses to pharmacological tests.
    Garnier PE; Raynaud F; Job JC
    Horm Res; 1985; 22(1-2):12-6. PubMed ID: 3897014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.